Fetal adverse events (14 events):
Congenital malformation (n = 10), Abnormal fetal heart rate (n = 1), Fetal kidney problem (n = 1), Unstable lie (n = 2).
Neonatal adverse events (15 events):
Premature births at <32 weeks (n = 5), n = 9
Congenital malformations (Exomphalos (n = 2), Talipes (n = 2), Anomalous pulmonary venous drainage, Bilateral cleft lip and palate, Enlarged clitoris, Perimembranneous and muscular venticular septal defect, Small sacral skin tag (all n = 1)), Shoulder dystocia (n = 1).
Control group:
Maternal adverse events (114 events): Generally unwell (n = 11), Symphysis pubis dysfunction (n = 11), Fainting/dizziness (n = 10), Oligohydramnios (n = 10), Early labour (n = 8), Nausea or vomiting (n = 8), Obstetric cholestasis (n = 7), Severe headaches (n = 6),
Vaginal discharge (n = 5), Polyhydramnios (n = 4), Thrombocytopenia (n = 2), Back pain (n = 4), Diarrhoea (n = 3), Oedema (n = 3), Epigastric pains (n = 2), Placental insufficiency (n 
Fetal adverse events (14 events):
Congenital malformation (n = 9), Unstable lie (n = 2), Abnormal fetal heart rate, Static growth on scan (< 10th centile), Unprovoked decelerations of fetal heart rate (all n = 1)
